Close
Novotech
Jabsco PureFlo 21 Single Use

Press Releases

Powerful Pumas Software for Drug Development Modeling and Simulation is Now Available for Desktop Download

Pumas-AI, a science-first organization that turns data into life-saving decisions faster, announced that its Pumas software is now available for desktop download. Pumas is a one-stop integrated modeling and simulation platform designed to multiply productivity across the drug development...

GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine

GreenLight Biosciences, a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture, and Samsung Biologics, a leading global CDMO providing fully integrated end-to-end contract development and manufacturing services, announced the successful...

Shimadzu’s Nexera XS Inert Chromatography System Enhances Biopharma Analysis

Shimadzu’s new ultra-high performance liquid chromatography system is designed to solve common problems in biopharma analysis. Shimadzu launched its new Nexera XS inert, a bioinert and biocompatible ultra-high performance liquid chromatograph (UHPLC), in July 2022. The system is designed to...

Roche Launches Dual Antigen and Antibody Hepatitis C Diagnostic Test

Roche’s new test is the first available immunoassay that allows for simultaneous, independent determination of the hepatitis C virus antigen and antibody status. Roche launched its Elecsys HCV Duo immunoassay (Elecsys) in July 2022, which is the first available immunoassay...

AES Clean Technology launches OMNI™ Electric Utility Raceway

AES Clean Technology, a leading provider of high-performance cleanroom facilities within the pharmaceutical and biopharmaceutical industry, announces the launch of its smart cable management system for cleanrooms – the AES OMNI™ Electric Utility Raceway. The OMNI™ Electric Utility Raceway is...

Merck and Orion Announce Global Collaboration for Oncology Drug

Merck, known as MSD outside the United States and Canada, and Orion Corporation are collaborating to develop and commercialize a treatment for metastatic castration-resistant prostate cancer. Merck, known as MSD outside the United States and Canada, announced a global development...

Tower Cold Chain Secures Further Investment to Supercharge its Success

Pharmaceutical temperature-controlled specialist Tower Cold Chain has secured £6.75million in investment, to reinforce the business as the leader in robust, reliable, and reusable cold chain solutions, following a period of rapid and sustained growth. The investment, backed by Investec, comes...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »